Pfizer is advancing Phase 2/3 clinical trials for young kids at lower doses than vaccines for adults, the pharmaceutical company announced Tuesday.
Children have historically been the group the least affected by the bioengineered, gain of function COVID-19 virus that was released from a lab in Wuhan China back in 2019. Even at the height of the manmade pandemic, the numbers of children affected by the virus were the lowest of all groups. So why now, when the virus is naturally beginning to abate and subside, is there a full-court press to stick a vaccine into kids as young as 2? Oh, I think you know.
"So they poured out for the men to eat. And it came to pass, as they were eating of the pottage, that they cried out, and said, O thou man of God, there is death in the pot. And they could not eat thereof." 2 Kings 4:40 (KJB)
Bill Gates' lifelong dream has been to vaccinate every person on the face of the earth, especially the children, and now we are all watching that dystopian nightmare coming true on a daily basis. I did my research over 25 years ago regarding vaccinating my own children, and my investigation led me to not vaccinate my children. To this day, thank the Lord, they all enjoy robust good health, with fully-functioning immune systems as God intended for it to be. I have been against vaccines for quite some time, and with everything I learn about the mRNA vaccine with its horrific side effects and death rate, I will not be changing my mind anytime soon. Pray very hard to God for wisdom before injecting your child, it cannot be undone.
SHOCK VIDEO OF BILL GATES LAUGHING WHILE SAYING ‘WE TAKE GMO ORGANISMS & SHOOT THEM RIGHT INTO LITTLE KIDS VEINS’ IN BRUSSELS INTERVIEW IN 2015
Pfizer advances clinical trials for 5- to 11-year-olds at lower doses
FROM ABC NEWS: Based on safety, efficacy and tolerability data from Pfizer's Phase 1 trial, the company will use 10 micrograms of each vaccine dose for kids between the ages of 5 and 11 in Phase 2/3 trials, and 3 micrograms of each dose for those 5 and younger. People ages 12 and older received 30 micrograms in each dose.
In addition to studying vaccine safety and side effects in kids, the study will examine antibody response to ensure the vaccine produces enough immunity at lower doses. The study will include up to 4,500 participants from the United States, Finland, Poland and Spain, according to Pfizer.
"Today marks an important next step in our efforts to understand the safety and immune response of our COVID-19 vaccine," Dr. Bill Gruber, senior vice president of clinical research and development at Pfizer, said in a statement. In the coming weeks, Phase 2/3 trials will start for 2- to 4-year-olds, as well as those as young as six months, according to Gruber.
"We take a deliberate and careful approach to help us understand the safety and how well the vaccine can be tolerated in younger children," Gruber said. "Children younger than 12 make up a significant portion of the total global population and can develop COVID-19 disease, and also can spread the virus to others," Gruber added. "If successful, we believe vaccinating children will help further protect our communities and contribute to the evolving herd immunity.”
Pfizer anticipates having initial results of the Phase 2/3 trials in September for the 5- to 11-year-old group, with results for kids of 2 and 5 expected shortly after that. Results for children between the ages of six months and 2 years old are expected in October or November, according to a Pfizer spokesperson.
In every instance, Pfizer would potentially apply for emergency use authorization in the U.S. shortly after getting results, assuming they showed the vaccines to be safe and effective in those age groups at those doses. READ MORE
No comments:
Post a Comment